| Company Name: |
|
| Tel: |
821-50328103-801 18930552037 |
| Email: |
3bsc@sina.com |
| Products Intro: |
Product Name:S(-)-ETICLOPRIDE HYDROCHLORIDE
CAS:84226-12-0
Purity:99% HPLC Package:1Mg ; 5Mg;10Mg ;100Mg;250Mg ;500Mg ;1g;2.5g ;5g ;10g
|
| Company Name: |
BOC Sciences
|
| Tel: |
|
| Email: |
info@bocsci.com |
| Products Intro: |
Product Name:Eticlopride
CAS:84226-12-0
Purity:98% Remarks:Eticlopride is a selective dopamine D2 antagonist . It was initially developed as a potential antipsychotic agent. Now Eticlopride is primarily used in pharmacological research.
|
| Company Name: |
Cayman Chemical Company
|
| Tel: |
800-364-9897 |
| Email: |
sales@caymanchem.com |
| Products Intro: |
Product Name:Eticlopride (hydrochloride)
|
| Company Name: |
Santa Cruz Biotechnology Inc
|
| Tel: |
60936350 |
| Email: |
scbt@scbt.com |
| Products Intro: |
Product Name:R (+)-Eticlopride hydrochloride
CAS:84226-12-0
|
| Company Name: |
Neobioscience Co., Ltd.
|
| Tel: |
4006-800-892 |
| Email: |
info@neobioscience.com |
| Products Intro: |
Product Name:Eticlopride (hydrochloride)
|
|
| | S(-)-ETICLOPRIDE HYDROCHLORIDE Basic information |
| Product Name: | S(-)-ETICLOPRIDE HYDROCHLORIDE | | Synonyms: | S(-)-3-CHLORO-5-ETHYL-N-[(1-ETHYL-2-PYRROLIDINYL)METHYL]6-HYDROXY-2 METHOXYBENZAMIDE HCL;S(-)-3-CHLORO-5-ETHYL-N-([1-ETHYL-2-PYRROLIDINYL]METHYL)-6-HYDROXY-2-METHOXYBENZAMIDE HYDROCHLORIDE;S(-)-ETICLOPRIDE HYDROCHLORIDE;Eticlopride;ETICLOPRIDE HYDROCHLORIDE;FLB 131;s(-)-eticlopride;(-)-3-Chloro-5-ethyl-N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-6-hydroxy-2-methoxybenzamide | | CAS: | 84226-12-0 | | MF: | C17H25ClN2O3 | | MW: | 340.85 | | EINECS: | | | Product Categories: | | | Mol File: | 84226-12-0.mol |  |
| | S(-)-ETICLOPRIDE HYDROCHLORIDE Chemical Properties |
| solubility | H2O: 12 mg/mL, soluble | | color | off-white |
| WGK Germany | 3 | | RTECS | CV2450000 |
| | S(-)-ETICLOPRIDE HYDROCHLORIDE Usage And Synthesis |
| Uses | R (+)-Eticlopride is a dopamine D2-receptor antagonist. | | Definition | ChEBI: 5-chloro-3-ethyl-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-hydroxy-6-methoxybenzamide is a member of salicylamides. | | in vivo | Eticlopride (10 mg/kg, i.p.) blocks normal vessel morphologyc restored by DA in orthotopic PC3 and HT29 tumor-bearing animals[2].
Eticlopride (0.01 or 0.02 mg/kg, i.p.) alleviates cognitive deficits produced by Quinpirole (HY-B1752) in rats[4].
| Animal Model: | Sprague-Dawley rats treated with Ruinpirole (1 mg/kg) from postnatal days 1 to 21[4] | | Dosage: | 0.01 or 0.02 mg/kg | | Administration: | i.p. | | Result: | Alleviated cognitive deficits produced by neonatal quinpirole treatment in both male and
female rats on the place version of the MWT, as well as in males tested on the match-to-place
version of the MwT (MwT tested on P22 to P28). |
|
| | S(-)-ETICLOPRIDE HYDROCHLORIDE Preparation Products And Raw materials |
|